Skip to main content

An insight into THEMIS trial

By 1 Settembre 2019Settembre 15th, 2021No Comments
Dai congressiInterviste

THEMIS trial showed significant reduction of ischaemic events in patients with stable CAD and type 2 diabetes using the combination of ticagrelor and aspirin, compared with aspirin alone. Deepak L. Bhatt (Brigham and Women’s Hospital, Harvard Medical School, Boston) summarises for us the key points of the trial at the ESC 2019 congress.